Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

SOFI Stock: 3 Things to Watch When SoFi Reports Earnings Jan. 29

SOFI stock is trending, as the company will report its fourth-quarter earnings on Monday, Jan. 29, before the market open.

Luke Lango Says Allbirds Stock Can Fly Higher in 2024

Luke Lango sees Allbirds as one of 2024's breakout sensations. Here's why he's bullish on BIRD stock at a time when many others are not.

Paramount Layoffs 2024: What to Know About the Latest PARA Job Cuts

Paramount layoffs are coming for an unknown number of employees as the media company enacts plans to become a leaner business.

Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls

A Robitussin recall is underway for two of the company's products after discovering microbial contamination of its cough syrups.

Is a Giant Short Squeeze Brewing in Riot Platforms (RIOT) Stock?

Riot Platforms (RIOT) stock is rallying after Bitcoin rose above $41,000. BTC's gains were sparked by a decline in outflows from a BTC ETF.

Dear FSR Stock Fans, Mark Your Calendars for Feb. 1

Fisker stock fans will want to mark their calendars for Feb. 1 as its presentation at the NADA show could be a catalyst for FSR shares.

Salesforce Layoffs 2024: What to Know About the Latest CRM Job Cuts

Salesforce layoffs are coming for 700 of the company's employees as it adjusts its headcount for a rough economy this year.

PYPL Stock Dips After PayPal Failed to ‘Shock the World’ at Its Innovation Day

PayPal overpromised and underdelivered at its Innovation Day event, sending PYPL stock down and disappointing analysts.

December PCE Report Shows Inflation Cooling. That’s Good News for Fed Rate Cuts.

The December PCE report showed cooling inflation, with core prices falling below 3% for the first time since March 2021.

Levi Strauss Layoffs 2024: What to Know About the Latest LEVI Job Cuts

Levi Strauss layoffs are coming for as much as 15% of its corporate workforce as it prepares for a rough economy in 2024.

Why Is SU Group (SUGP) Stock Moving Today?

SU Group stock volatile on Friday following the company's IPO earlier this week with shares currently trading below its debut price.

Why Is Aptose Biosciences (APTO) Stock Down Today?

Aptose Biosciences stock is sliding lower on Friday as investors react to a public offering and private placement for APTO shares.

Why Is Ekso Bionics (EKSO) Stock Up 5% Today?

Ekso Bionics stock is rising higher on Friday without any clear news from the exoskeleton company and no heavy trading activity.

Why Is Aclarion (ACON) Stock Up 109% Today?

Aclarion stock is rising higher on Friday with heavy trading of ACON stock despite a lack of news from the company this morning.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning!

Hut 8 (HUT) Stock Pops as Bitcoin Miner Battles Short Seller

HUT stock is surging higher after Hut 8 issued a response to J Capital's short report, alleging the short seller of spreading misinformation.

UBS Is Doubling Down on Advanced Micro Devices (AMD) Stock

Advanced Micro Devices (AMD) stock is in the green today after UBS raised its price target on the chipmaker to $220 per share, from $135.

Fisker (FSR) Stock Looks Primed for a Short Squeeze with 28% Short Interest

FSR stock commands a high short interest as a percentage of float as well as a high cost to borrow fee. Could shorts be squeezed out?

Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?

Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.